Burton Lee Kennedy, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Shadowline Dr, Suite 202, Boone, NC 28607 Phone: 828-262-0600 |
Ms. Margaret Louise Craig, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 895 State Farm Rd, Suite 508, Boone, NC 28607 Phone: 828-264-9007 Fax: 828-262-5687 |
Dr. Suzanne Elaine Mcadams, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 895 State Farm Rd, Suite 501, Boone, NC 28607 Phone: 828-264-7720 Fax: 828-264-7636 |
Phyllis Sage Atwell, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 152 Southgate Dr, Suite 3a, Boone, NC 28607 Phone: 828-265-4370 Fax: 828-265-4354 |
Mr. Marshall Jay Stein, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 132 Poplar Grove Connector, Suite B, Boone, NC 28607 Phone: 828-264-8759 Fax: 828-262-5687 |
Dr. Jeffrey Paul Crittenden, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Shadowline Dr, Suite 202, Boone, NC 28607 Phone: 828-262-0600 Fax: 828-262-0807 |
Dr. Alycia Brown, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1760 Nc Hwy 105, Boone, NC 28607 Phone: 828-202-9765 Fax: 877-847-0561 |
News Archive
With some of the lowest death and incidence rates for cancers, British Columbia is leading Canada in the battle against cancer.
USMD Holdings, Inc., a physician-led integrated healthcare system, announces that it has entered into a definitive agreement to sell most of its lithotripsy division to United Medical Systems (UMS), a leading provider of mobile medical equipment and services, including urology, women's health and MRI imaging, to hospitals, surgery centers and physician offices across the U.S., Canada and South America.
A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related).
Celsion Corporation today announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K. Libutti, Professor and Vice Chairman, Department of Surgery and Director of the Montefiore-Einstein Center for Cancer Care and Albert Einstein College of Medicine in New York City, will serve as Principal Investigator for the study.
› Verified 6 days ago